Literature DB >> 19412573

Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease.

Nitin Mahajan1, Namita Malik, Ajay Bahl, Yashpaul Sharma, Veena Dhawan.   

Abstract

Studies are lacking in literature, which demonstrate the cumulative impact of certain soluble markers in predicting the severity of CAD. Serum hsCRP, MMP-9, TIMP-1 and sRAGE levels were measured in non-diabetic 100 angiographically proven CAD patients (Group I) and 40 non-diabetic subjects with coronary risk factors and without any lesions (Group II). Increased levels of serum hsCRP, MMP-9, TIMP-1 and decreased levels of sRAGE were observed in Group I as compared to Group II. Gensini score, a measure for severity of CAD was found to be positively correlated with serum hsCRP, MMP-9, TIMP-1 and negatively with sRAGE. Multivariate analysis revealed serum MMP-9, hsCRP, sRAGE and family history as predictors of severity of CAD with a cumulative sensitivity and specificity of 92% and 82%, respectively. Cumulative impact of these soluble markers, in addition to the established markers will contribute to improve the predictive value for the assessment of disease severity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19412573     DOI: 10.1007/s11010-009-0134-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

Review 1.  Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance.

Authors:  Muzahir H Tayebjee; Gregory Y H Lip; Robert J MacFadyen
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

2.  Decreased plasma levels of soluble receptor for advanced glycation end products in mild cognitive impairment.

Authors:  R Ghidoni; L Benussi; M Glionna; M Franzoni; D Geroldi; E Emanuele; G Binetti
Journal:  J Neural Transm (Vienna)       Date:  2008-05-28       Impact factor: 3.575

3.  World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

Authors: 
Journal:  Cardiovasc Res       Date:  1997-07       Impact factor: 10.787

4.  Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity.

Authors:  A B Zaltsman; S J George; A C Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-07       Impact factor: 8.311

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.

Authors:  Diego Geroldi; Colomba Falcone; Enzo Emanuele; Angela D'Angelo; Margherita Calcagnino; Maria P Buzzi; Giuseppe A Scioli; Roberto Fogari
Journal:  J Hypertens       Date:  2005-09       Impact factor: 4.844

7.  Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.

Authors:  Enzo Emanuele; Angela D'Angelo; Carmine Tomaino; Giuliano Binetti; Roberta Ghidoni; Pierluigi Politi; Livia Bernardi; Raffaele Maletta; Amalia C Bruni; Diego Geroldi
Journal:  Arch Neurol       Date:  2005-11

8.  Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

Authors:  Colomba Falcone; Enzo Emanuele; Angela D'Angelo; Maria P Buzzi; Chiara Belvito; Mariaclara Cuccia; Diego Geroldi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

9.  C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes.

Authors:  I Abdelmouttaleb; N Danchin; C Ilardo; I Aimone-Gastin; M Angioï; A Lozniewski; J Loubinoux; A Le Faou; J L Guéant
Journal:  Am Heart J       Date:  1999-02       Impact factor: 4.749

10.  Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.

Authors:  J L Anderson; J F Carlquist; J B Muhlestein; B D Horne; S P Elmer
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

View more
  9 in total

1.  Analysis of traditional and emerging risk factors in premenopausal women with coronary artery disease: A pilot-scale study from North India.

Authors:  Rajesh Vijayvergiya; Divya Kapoor; Ajay Aggarwal; Sonal Sangwan; Vanita Suri; Veena Dhawan
Journal:  Mol Cell Biochem       Date:  2017-03-23       Impact factor: 3.396

2.  Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.

Authors:  Radana Gurecká; Ivana Koborová; Melinda Csongová; Jozef Šebek; Katarína Šebeková
Journal:  Glycoconj J       Date:  2016-06-14       Impact factor: 2.916

3.  The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis.

Authors:  Mohammad Assadpour Piranfar
Journal:  Int Cardiovasc Res J       Date:  2014-01-01

Review 4.  Acknowledged signatures of matrix metalloproteinases in Takayasu's arteritis.

Authors:  Gang Wu; Nitin Mahajan; Veena Dhawan
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

5.  Association between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and the activity of semicarbazide-sensitive amine oxidase.

Authors:  Ivana Koborová; Radana Gurecká; Melinda Csongová; Katarína Volkovová; Éva Szökő; Tamás Tábi; Katarína Šebeková
Journal:  Croat Med J       Date:  2017-04-14       Impact factor: 1.351

6.  Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.

Authors:  Sakhavat Abolhasani; Shahnam Valizadeh Shahbazloo; Hossein Mozafar Saadati; Neda Mahmoodi; Nafiseh Khanbabaei
Journal:  Arq Bras Cardiol       Date:  2019-08-29       Impact factor: 2.000

7.  Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women.

Authors:  Soumitra Ghosh; Divya Kapoor; Rajesh Vijayvergiya; Sonal Sangwan; Sujata Wangkheimayum; Sakshi Mehta; Veena Dhawan
Journal:  World J Cardiol       Date:  2021-05-26

8.  Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease.

Authors:  Colomba Falcone; Sara Bozzini; Luigina Guasti; Angela D'Angelo; Anna Clizia Capettini; Edoardo Maria Paganini; Rossana Falcone; Roberto Moia; Carmine Gazzaruso; Gabriele Pelissero
Journal:  ScientificWorldJournal       Date:  2013-10-09

Review 9.  High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective.

Authors:  Deepak Y Kamath; Denis Xavier; Alben Sigamani; Prem Pais
Journal:  Indian J Med Res       Date:  2015-09       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.